-
Potential Gene Therapy for Duchenne MD Could Improve Microdystrophin Production in Muscles
Early findings in three Duchenne MD patients treated with SGT-001at low dose in a Phase 1/2 study show low levels of microdystrophin evident in muscles. Click here to learn more about what this could mean for patients with DMD.
What are your thoughts on this news?
Sorry, there were no replies found.
Log in to reply.